Report Detail
Global Pregabalin Market Insights, Forecast to 2025
- RnM2692092 |
- 04 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market.
The global Pregabalin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pregabalin market based on company, product type, end user and key regions.
This report studies the global market size of Pregabalin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pregabalin in these regions.
This research report categorizes the global Pregabalin market by top players/brands, region, type and end user. This report also studies the global Pregabalin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer Inc.
Torrent Pharmaceuticals Ltd.
Lupin Limited
Zydus Cadila Healthcare Ltd.
Cipla Limited
Genesis Remedies
Sanofi
Medley Pharmaceuticals Limited
Genesis Biotec Inc.
Biomax
Market size by Product
Epilepsy
Neuropathic Pain
Fibromyalgia
Generalized Anxiety Disorder
Market size by End User
Research Institutes
Pharmaceutical Companies
Others (Hospitals and Clinics)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pregabalin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pregabalin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pregabalin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pregabalin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pregabalin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pregabalin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pregabalin Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pregabalin Market Size Growth Rate by Product
- 1.4.2 Epilepsy
- 1.4.3 Neuropathic Pain
- 1.4.4 Fibromyalgia
- 1.4.5 Generalized Anxiety Disorder
- 1.5 Market by End User
- 1.5.1 Global Pregabalin Market Size Growth Rate by End User
- 1.5.2 Research Institutes
- 1.5.3 Pharmaceutical Companies
- 1.5.4 Others (Hospitals and Clinics)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pregabalin Market Size
- 2.1.1 Global Pregabalin Revenue 2014-2025
- 2.1.2 Global Pregabalin Sales 2014-2025
- 2.2 Pregabalin Growth Rate by Regions
- 2.2.1 Global Pregabalin Sales by Regions
- 2.2.2 Global Pregabalin Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pregabalin Sales by Manufacturers
- 3.1.1 Pregabalin Sales by Manufacturers
- 3.1.2 Pregabalin Sales Market Share by Manufacturers
- 3.1.3 Global Pregabalin Market Concentration Ratio (CR5 and HHI)
- 3.2 Pregabalin Revenue by Manufacturers
- 3.2.1 Pregabalin Revenue by Manufacturers (2014-2019)
- 3.2.2 Pregabalin Revenue Share by Manufacturers (2014-2019)
- 3.3 Pregabalin Price by Manufacturers
- 3.4 Pregabalin Manufacturing Base Distribution, Product Types
- 3.4.1 Pregabalin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pregabalin Product Type
- 3.4.3 Date of International Manufacturers Enter into Pregabalin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pregabalin Sales by Product
- 4.2 Global Pregabalin Revenue by Product
- 4.3 Pregabalin Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pregabalin Breakdown Data by End User
6 North America
- 6.1 North America Pregabalin by Countries
- 6.1.1 North America Pregabalin Sales by Countries
- 6.1.2 North America Pregabalin Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pregabalin by Product
- 6.3 North America Pregabalin by End User
7 Europe
- 7.1 Europe Pregabalin by Countries
- 7.1.1 Europe Pregabalin Sales by Countries
- 7.1.2 Europe Pregabalin Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pregabalin by Product
- 7.3 Europe Pregabalin by End User
8 Asia Pacific
- 8.1 Asia Pacific Pregabalin by Countries
- 8.1.1 Asia Pacific Pregabalin Sales by Countries
- 8.1.2 Asia Pacific Pregabalin Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pregabalin by Product
- 8.3 Asia Pacific Pregabalin by End User
9 Central & South America
- 9.1 Central & South America Pregabalin by Countries
- 9.1.1 Central & South America Pregabalin Sales by Countries
- 9.1.2 Central & South America Pregabalin Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pregabalin by Product
- 9.3 Central & South America Pregabalin by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pregabalin by Countries
- 10.1.1 Middle East and Africa Pregabalin Sales by Countries
- 10.1.2 Middle East and Africa Pregabalin Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pregabalin by Product
- 10.3 Middle East and Africa Pregabalin by End User
11 Company Profiles
- 11.1 Pfizer Inc.
- 11.1.1 Pfizer Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Inc. Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Inc. Pregabalin Products Offered
- 11.1.5 Pfizer Inc. Recent Development
- 11.2 Torrent Pharmaceuticals Ltd.
- 11.2.1 Torrent Pharmaceuticals Ltd. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Torrent Pharmaceuticals Ltd. Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Torrent Pharmaceuticals Ltd. Pregabalin Products Offered
- 11.2.5 Torrent Pharmaceuticals Ltd. Recent Development
- 11.3 Lupin Limited
- 11.3.1 Lupin Limited Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Lupin Limited Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Lupin Limited Pregabalin Products Offered
- 11.3.5 Lupin Limited Recent Development
- 11.4 Zydus Cadila Healthcare Ltd.
- 11.4.1 Zydus Cadila Healthcare Ltd. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Zydus Cadila Healthcare Ltd. Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Zydus Cadila Healthcare Ltd. Pregabalin Products Offered
- 11.4.5 Zydus Cadila Healthcare Ltd. Recent Development
- 11.5 Cipla Limited
- 11.5.1 Cipla Limited Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cipla Limited Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cipla Limited Pregabalin Products Offered
- 11.5.5 Cipla Limited Recent Development
- 11.6 Genesis Remedies
- 11.6.1 Genesis Remedies Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Genesis Remedies Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Genesis Remedies Pregabalin Products Offered
- 11.6.5 Genesis Remedies Recent Development
- 11.7 Sanofi
- 11.7.1 Sanofi Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanofi Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanofi Pregabalin Products Offered
- 11.7.5 Sanofi Recent Development
- 11.8 Medley Pharmaceuticals Limited
- 11.8.1 Medley Pharmaceuticals Limited Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Medley Pharmaceuticals Limited Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Medley Pharmaceuticals Limited Pregabalin Products Offered
- 11.8.5 Medley Pharmaceuticals Limited Recent Development
- 11.9 Genesis Biotec Inc.
- 11.9.1 Genesis Biotec Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Genesis Biotec Inc. Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Genesis Biotec Inc. Pregabalin Products Offered
- 11.9.5 Genesis Biotec Inc. Recent Development
- 11.10 Biomax
- 11.10.1 Biomax Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Biomax Pregabalin Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Biomax Pregabalin Products Offered
- 11.10.5 Biomax Recent Development
12 Future Forecast
- 12.1 Pregabalin Market Forecast by Regions
- 12.1.1 Global Pregabalin Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pregabalin Revenue Forecast by Regions 2019-2025
- 12.2 Pregabalin Market Forecast by Product
- 12.2.1 Global Pregabalin Sales Forecast by Product 2019-2025
- 12.2.2 Global Pregabalin Revenue Forecast by Product 2019-2025
- 12.3 Pregabalin Market Forecast by End User
- 12.4 North America Pregabalin Forecast
- 12.5 Europe Pregabalin Forecast
- 12.6 Asia Pacific Pregabalin Forecast
- 12.7 Central & South America Pregabalin Forecast
- 12.8 Middle East and Africa Pregabalin Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pregabalin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pregabalin . Industry analysis & Market Report on Pregabalin is a syndicated market report, published as Global Pregabalin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pregabalin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
